AQR Capital Management - ARROWHEAD PHARMACEUTICALS IN ownership

ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 315 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q4 2020. The put-call ratio across all filers is 0.54 and the average weighting 0.4%.

Quarter-by-quarter ownership
AQR Capital Management ownership history of ARROWHEAD PHARMACEUTICALS IN
ValueSharesWeighting
Q4 2022$240,900
-68.3%
6,024
-73.8%
0.00%
-50.0%
Q3 2022$759,000
+16.4%
22,952
+17.5%
0.00%
+100.0%
Q2 2022$652,000
-87.8%
19,540
-83.2%
0.00%
-90.0%
Q1 2022$5,362,000
+67.4%
116,598
+141.3%
0.01%
+66.7%
Q4 2021$3,204,000
-10.1%
48,330
-16.1%
0.01%
-14.3%
Q3 2021$3,565,000
-3.8%
57,593
+27.5%
0.01%
+16.7%
Q2 2021$3,705,000
+115.3%
45,166
+74.0%
0.01%
+100.0%
Q1 2021$1,721,000
-37.4%
25,954
-28.1%
0.00%
-40.0%
Q4 2020$2,749,000
-10.6%
36,098
-49.5%
0.01%0.0%
Q3 2020$3,076,000
-74.6%
71,426
-75.1%
0.01%
-75.0%
Q2 2020$12,103,000
-4.0%
286,330
-34.6%
0.02%
-4.8%
Q1 2020$12,602,000
+57.4%
438,025
+247.1%
0.02%
+133.3%
Q4 2019$8,005,000
+71.0%
126,196
-24.0%
0.01%
+50.0%
Q3 2019$4,680,000
-49.8%
166,077
-52.8%
0.01%
-40.0%
Q2 2019$9,320,000
+161.9%
351,710
+81.3%
0.01%
+150.0%
Q1 2019$3,559,000
+147.0%
193,951
+67.2%
0.00%
+100.0%
Q4 2018$1,441,000
-31.7%
116,013
+5.4%
0.00%0.0%
Q3 2018$2,110,000
+20.8%
110,079
-14.3%
0.00%0.0%
Q2 2018$1,747,000
+3617.0%
128,421
+324.8%
0.00%
Q4 2016$47,00030,2320.00%
Other shareholders
ARROWHEAD PHARMACEUTICALS IN shareholders Q4 2020
NameSharesValueWeighting ↓
WESTERN FINANCIAL Corp 820,328$51,213,00030.37%
JOHNSON & JOHNSON 3,260,869$203,576,00017.86%
ACT CAPITAL MANAGEMENT, LLC 194,000$12,111,0006.28%
Aquilo Capital Management, LLC 527,926$32,958,0005.99%
Evolutionary Tree Capital Management, LLC 105,491$6,586,0002.92%
ACUTA CAPITAL PARTNERS, LLC 121,500$7,585,0002.68%
L1 Capital Pty Ltd 297,915$18,599,0002.31%
Avidity Partners Management LP 673,700$42,059,0000.93%
Hood River Capital Management LLC 338,734$21,147,0000.65%
Tygh Capital Management, Inc. 64,127$4,003,0000.54%
View complete list of ARROWHEAD PHARMACEUTICALS IN shareholders